Featured White Papers
- Hosted CRM buyer's guide (Inside CRM)
- Hosted CRM comparison guide (Inside CRM)
- Enterprise PBX buyer's guide (VoIP-News)
Gender discrimination within the reproductive health care system: Viagra v. birth control.
Journal of Law and Health, June, 1998 by Hayden, Lisa A.
I. INTRODUCTION
Recently, Pfizer Inc. drew nationwide attention by announcing the Federal Drug Administration (hereinafter "FDA") approval of its impotence pill, Viagra. Dubbed as the "magic blue pill," early studies indicate that Viagra enables men diagnosed with impotence to become aroused and engage in sexual intercourse.(2) National attention surrounding Viagra has prompted many insurance carriers to cover at least a part of the cost of the prescription.(3) In fact, by May 1, 1998 nearly half of all Viagra prescriptions were subsidized by insurance ...
Read the rest of this article with a Free Trial at HighBeam Research.